Skip to main content
. 2017 Jan 6;13:41–48. doi: 10.2147/TCRM.S125480

Table 3.

The association of nephrolithiasis with MetS and its components

Characteristics No of participants Nephrolithiasis Non-nephrolithiasis OR 95% CI P-value
Total, n (%) 3,793 (100) 639 (16.8) 3,154 (83.2) <0.001
 Non-MetS 2,826 (74.5) 416 (14.7) 2,410 (85.3) 1.000 (reference) 1.000 (reference)
 MetS 967 (25.5) 223 (23.1) 744 (76.9) 1.736 1.447–2.084
No of metS components <0.001
 0 931 (24.5) 98 (10.5) 833 (89.5) 1.000 (reference) 1.000 (reference)
 1 1,081 (28.5) 164 (15.2) 917 (84.8) 1.520 1.164–1.986
 2 814 (21.5) 154 (18.9) 660 (81.1) 1.989 1.509–2.606
 3 551 (14.5) 116 (21.1) 435 (78.9) 2.267 1.691–3.038
 4 316 (8.3) 81 (25.6) 235 (74.4) 2.930 2.111–4.067
 5 100 (2.6) 26 (26) 74 (74) 2.986 1.823–4.892
Gender <0.001
 Female 1,675 (44.2) 205 (12.2) 1,470 (87.8) 1.000 (reference) 1.000 (reference)
 Male 2,118 (55.8) 434 (20.5) 1,684 (79.5) 1.848 1.543–2.213
Waist circumference (cm) <0.001
 Normal 2,797 (73.7) 424 (15.2) 2,373 (84.8) 1.000 (reference) 1.000 (reference)
 Larger 996 (26.3) 215 (21.6) 781 (78.4) 1.541 1.283–1.850
Blood pressure (mmHg) <0.001
 Normal 1,928 (50.8) 246 (12.8) 1,682 (87.2) 1.000 (reference) 1.000 (reference)
 Higher 1,865 (49.2) 393 (21.1) 1,472 (78.9) 1.825 1.534–2.172
HDL cholesterol (mg/dL) 0.024
 Normal 2,405 (63.4) 380 (15.8) 2,025 (84.2) 1.000 (reference) 1.000 (reference)
 Lower 1,388 (36.6) 259 (18.7) 1,129 (81.3) 1.222 1.027–1.455
Triglycerides (mg/dL) 0.002
 Normal 2,985 (78.7) 473 (15.8) 2,512 (84.2) 1.000 (reference) 1.000 (reference)
 Higher 808 (21.3) 166 (20.5) 642 (79.5) 1.373 1.128–1.672
Fasting glucose (mg/dL) <0.001
 Normal 2,724 (71.8) 398 (14.6) 2,326 (85.4) 1.000 (reference) 1.000 (reference)
 Higher 1,069 (28.2) 241 (22.5) 828 (77.5) 1.701 1.423–2.034

Abbreviations: OR, odds ratio; CI, confidence interval; MetS, metabolic syndrome; HDL, high-density lipoprotein.